Combining pharmacotherapy with cognitive behavioral therapy: traditional and new approaches.
Given the ever-increasing sources of trauma both nationally and globally, it is imperative to develop new and better treatments for anxiety disorders such as posttraumatic stress disorder (PTSD). This review is a collection of presentations that seek to do just that, either by using pharmacotherapy to try to prevent or erase the formation of traumatic fear memories, or to enhance exposure-based cognitive-behavioral therapy using pharmacological agents that have been effective in enhanced extinction of fear in rodents.
Davis
Michael
M
Department of Psychiatry, Emory University, Atlanta, GA, USA. mdavis4@emory.edu
Barad
Mark
M
Otto
Michael
M
Southwick
Stephen
S
D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003887:Desensitization, Psychologic; D019317:Evidence-Based Medicine; D005239:Fear / Q000187:drug effects; D006801:Humans; D011939:Mental Recall / Q000187:drug effects; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D013313:Stress Disorders, Post-Traumatic / Q000628:therapy*
D011619:Psychotropic Drugs